Bellvitge Biomedical Research Institute (IDIBELL) is a research center in biomedicine participated by l'Hospital Universitari de Bellvitge and l’Hospital de Viladecans from the Catalan Health Institute, the Institut Català d'Oncologia, Universitat de Barcelona and Ajuntament de l’Hospitalet de Llobregat. In 2017, the Center for Regenerative Medicine of Barcelona (CMR [B]) began the establishment of the Regenerative Medicine Program of Catalonia (P-CMR [C]) with IDIBELL.
The research focuses of IDIBELL are cancer, neuroscience, translational medicine and regenerative medicine; Research, innovation and society are the pivots on which researchers work every day in order to improve the quality of life of citizens.
IDIBELL is situated at Hospitalet de Llobregat, at the south of Barcelona. The center is certified as a health research institute by the Instituto de Salud Carlos III; also is member of Campus d'Excel·lència Internacional de la Universitat de Barcelona HUBc and the institution CERCA from the Generalitat de Catalunya. Importantly, the institute has received the 'HR Excellence in Research' logo from the European Comission.